Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Key: TheraVitae Ltd. (0) Acquired (1)
autologous angiogenic cell precursors (1 trial)
angiogenic cell precursors (1 trial)
Heart Failure (Phase 1)
Ischemia (Phase 2)
Peripheral Arterial Disease (Phase 2)
Trials (2 total)
Trial APIs (2 total)